Coronavirus pseudovirus packaging system and packaging method, and application of coronavirus pseudovirus to evaluating disinfection efficacy
A coronavirus and packaging system technology, applied in the direction of applications, viruses, and viral peptides, can solve the problems of lack of evaluation methods for the ability of disinfectants to inactivate viruses, uneven virus inactivation capabilities, and lack of data support in the scope of application. Fast, easy to operate, high biosafety results
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0065] Example 1 Construction of different types of envelope plasmids:
[0066] According to the codon-optimized sequence of the S gene released by NCBI to facilitate its expression in cells, the sequences were synthesized by Nanjing GenScript Biotechnology into pCDNA3.1 vectors, and the target genes were amplified by PCR and recovered by fragment purification kits Purify the target band, digest the fragment and the pCAGGS vector with restriction endonucleases MCS1 (Xhol) and MCS2 (Nhel) at 37°C for 3 hours, recover the carrier and the target fragment from the gel, perform a ligation reaction, and then transfer to a competent state Cells and bacterial liquid PCR screened positive clones and enzyme digestion and sequencing to verify and identify the construction of the plasmid. The specific implementation steps are as follows: 1. Primer synthesis and primer information: The primers were synthesized by Suzhou Jinweizhi Biotechnology Co., Ltd., which was constructed to amplify COV...
Embodiment 2
[0099] Example 2 The infection of VSV-COVID-19-S-C19-HA on 293T-hACE2 cells showed higher efficiency:
[0100] In order to obtain the VSV pseudovirus of the spike protein (S) of different truncated forms of COVID-19, plasmids pCAGGS-COVID-19-S, pCAGGS-COVID-19-S-C19, pCAGGS-COVID-19-S-C19- HA, pCAGGS-COVID-19-S-C27, and pCAGGS-COVID-19-S-C53 were transfected into 293T cells by liposomes (lipo2000). 12 hours after transfection, inoculate dVSVΔG-Fluc-EGFP (preserved in the laboratory), i.e., VSV replication-defective virus strains, into the cells expressing the complete spike protein of COVID-19 or COVID-19-S-C19 / C27 / C53 / C19 respectively. -In the medium corresponding to the cells of the HA truncated protein (eukaryotic expression plasmids were transiently transformed 12h in advance), the supernatant was collected, and anti-VSV-G neutralizing serum was added to block the residual dVSVΔG-Fluc- in the cell supernatant. The infectivity of EGFP, the progeny virus was harvested, and ...
Embodiment 3
[0103] Example 3 The titer of dVSVΔG-COVID-19-S-C19-HA pseudovirus packaged in 293T cells is the highest
[0104]The packaging efficiency of the new coronavirus pseudovirus is one of the main limiting factors for high-throughput detection of neutralizing antibody tests in vitro. In order to select the most suitable cell line for the production of 2019-nCoV pseudotyped virus, conventional cells such as Vero-E6, BHK21, 293T-hACE2 and 293 were compared in this technique by pre-plating different cell lines in 6-well cell culture plates, The first choice is to transfect plasmids of different concentrations in the above-mentioned different cell lines, and then refer to the following one-step packaging method to package the dVSVΔG-COVID-19-S-C19-HA new coronavirus pseudovirus. The specific implementation steps are as follows:
[0105] 1) Vero / BHK21 / 293T / 293T-hACE2 cells were plated in a 6-well plate, and the cell density should be around 70% after 24 hours;
[0106] 2) pCAGGS-S / pCAG...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com